VENUS REMEDIES Q2 FY27 ; NET PROFIT UP 27% AT ₹26 CR (YOY), UP 12% (QOQ)

REVENUE UP 13% AT ₹219 CR (YOY), UP 22% (QOQ) EBITDA UP 37% AT ₹42 CR (YOY), UP 24% (QOQ) MARGINS AT 19.4% VS 16.1% (YOY), 19.1% (QOQ)

VENUS REMEDIES LTD.